ROTATEQ ORAL VACCINE Oral solution Saúdská Arábie - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

rotateq oral vaccine oral solution

merck sharp & dohme, netherlands - g1 reassortant,g2 reassortant,g3 reassortant,g4 reassortant,pia 8 reassortant - oral solution - nlt2.2*106,nlt2.8*106,nlt2.2*106,nlt2.0*106,nlt2.3*106 iu,

Rotavirus Vaccine, Live Attenuated (Oral) Oral Drops Keňa - angličtina - Pharmacy and Poisons Board

rotavirus vaccine, live attenuated (oral) oral drops

serum institute of india pvt. ltd 212/2 hadapsar, off soli-poonawalla road, pune- - live attenuated rotavirus vaccine (oral) - oral drops - each dose of 2.5 ml contains live attenuated… - rota virus pentavalent live reassorted

Rotavirus Vaccine, Live Attenuated (Oral) Oral Drops, Liquid Keňa - angličtina - Pharmacy and Poisons Board

rotavirus vaccine, live attenuated (oral) oral drops, liquid

live attenuated rotavirus vaccine (oral) - oral drops, liquid - each dose of 2.5 ml contains: live attenuated… - rota virus pentavalent live reassorted

RotaTeq solution oral Arménie - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rotateq solution oral

merck sharp & dohme b.v. waarderweg 39 - rotavirus type g1, rotavirus type g2, rotavirus type g3, rotavirus type g4, rotavirus type p1a - solution oral - not less than 2,2x10^6iu+ not less than 2,8x10^6iu+ not less than 2,2x10^6iu+ not less than 2x10^6iu+ not less than 2,3x10^6iu

RotaTeq solution oral Arménie - angličtina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rotateq solution oral

merck sharp & dohme b.v. waarderweg 39 - rotavirus type g1, rotavirus type g2, rotavirus type g3, rotavirus type g4, rotavirus type p1a - solution oral - not less than 2,2x10^6iu+ not less than 2,8x10^6iu+ not less than 2,2x10^6iu+ not less than 2x10^6iu+ not less than 2,3x10^6iu

Rotarix Oral Vaccine Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

rotarix oral vaccine

glaxosmithkline nz limited - live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) - oral suspension - 1e+006 ccid50 - active: live attenuated human rotavirus 1e+006 ccid50 ((rix 4414 strain)) excipient: di-sodium adipate dulbecco's modified eagle medium sucrose water for injection - rotarix is indicated for the prevention of rotavirus gastroenteritis

RotaTeq Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

rotateq

merck sharp & dohme (new zealand) limited - rotavirus reassortant strain g1 2.2e+006 [iu] (nlt, at expiry); rotavirus reassortant strain g2 2.8e+006 [iu] (nlt, at expiry); rotavirus reassortant strain g3 2.2e+006 [iu] (nlt, at expiry); rotavirus reassortant strain g4 2e+006 [iu] (nlt, at expiry); rotavirus reassortant strain p1 2.3e+006 [iu] (nlt, at expiry) - oral solution - 2 ml - active: rotavirus reassortant strain g1 2.2e+006 [iu] (nlt, at expiry) rotavirus reassortant strain g2 2.8e+006 [iu] (nlt, at expiry) rotavirus reassortant strain g3 2.2e+006 [iu] (nlt, at expiry) rotavirus reassortant strain g4 2e+006 [iu] (nlt, at expiry) rotavirus reassortant strain p1 2.3e+006 [iu] (nlt, at expiry) excipient: rotavirus diluent & lpkm-3 (from actives) to approx 0.3 ml. includes animal materials as below. monobasic sodium phosphate monohydrate polysorbate 80 purified water sodium citrate dihydrate sodium hydroxide sucrose - rotateq is an oral pentavalent vaccine indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes g1, g2, g3, g4, and g-serotypes that contain p1a[8] (e.g., g9). rotateq may be administered as early as six weeks of age.